BAFIARS - Biomedical Assessment of Function and Imaging of the Ano-rectal Sphincter
NCT ID: NCT02778048
Last Updated: 2019-01-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
SUSPENDED
50 participants
OBSERVATIONAL
2019-07-31
2020-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Subsequently, the knowledge of the anatomical and biomechanical properties of the anal sphincter complex are of cardinal importance. Most of the existing data on anatomy and physiology results is based on old studies and almost no data on biomechanical properties are available. However, new technologies or even merging data from different examination methods might provide new information in this field.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of the Efficacy of a Biological Implant to Reinforce Overlapping Sphincter Repair Versus Overlapping Sphincter Repair Alone
NCT01044589
Breakthrough Improvement Collaborative for Ventral Mesh Rectopexy
NCT05728554
Trans-perineal Repair With or Without Limited Internal Sphincterotomy for Treatment of Type I Anterior Rectocele
NCT02659176
Parental Attitudes to Neoanus Dilatations Post-reconstruction in Anorectal Malformations
NCT05749406
Ligation of the Intersphincteric Fistula Tract (LIFT) + Biodesign for Anal Fistula
NCT01602081
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Objective Primary objective is to collect anatomical, physiological and biomechanical characteristics of the continence organ (sphincters and pelvic floor) in patients suffering from fecal incontinence and to compare this data with data gathered in an earlier study (NCT02263170) on healthy volunteers.
Secondary objectives are: test feasibility of FLIP in measuring the biomechanical properties of the anal canal and test feasibility of merging 3D US data and MR images.
Methods For the assessment of the morphology ultra sound and MRI will be used, whereas FLIP (functional luminance imaging probe) and HRAM (high resolution anal manometry) are the modality of choice to investigate the biomechanical properties of the sphincter complex.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
fecal incontinence patients (m/f)
patients suffering from fecal incontinence (m/f) are going to be assessed via MRI, US, FLIP, and HRAM
MRI (magnetic resonance imaging)
Assessment of the sphincter
US (ultra sound)
Assessment of the sphincter
FLIP (functional lumen imaging probe)
Assessment of the sphincter
HRAM (high resolution anal manometry)
Assessment of the sphincter
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MRI (magnetic resonance imaging)
Assessment of the sphincter
US (ultra sound)
Assessment of the sphincter
FLIP (functional lumen imaging probe)
Assessment of the sphincter
HRAM (high resolution anal manometry)
Assessment of the sphincter
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Wexner score \>= 12
* Longo's obstructed defecation syndrome (ODS) score =0
* MRI safety (no metallic implants. Appendix MRI safety form)
* Normal weighted (20\<BMI\<30)
* Age ≥ 60 years
Exclusion Criteria
* Known or suspected non-compliance, drug or alcohol abuse
* Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nano-Tera.ch, Lausanne
UNKNOWN
Kantonsspital Winterthur KSW
OTHER
University of Bern
OTHER
University of Basel
OTHER
Insel Gruppe AG, University Hospital Bern
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lukas Brügger, PD, Dr. med.
Role: PRINCIPAL_INVESTIGATOR
University of Bern
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Bern
Bern, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KEK BE 359/15
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.